| 1. |
Kang Y, Zhang ZJ, Zhao XY, et al. Total hip arthroplasty for vascular necrosis of the femoral head in patients with systemic lupus erythematosus:a midterm follow-up study of 28 hips in 24 patients[J]. Eur J Orthop Surg Traumatol, 2013, 23(1):73-79.
|
| 2. |
Woo MS, Kang JS, Moon KH. Outcome of total hip arthroplasty for avascular necrosis of the femoral head in systemic lupus erythematosus[J]. J Arthroplasty, 2014, 29(12):2267-2270.
|
| 3. |
Issa K, Naziri Q, Rasquinha VJ, et al. Outcomes of primary total hip arthroplasty in systemic lupus erythematosus with a proximally-coated cementless stem[J]. J Arthroplasty, 2013, 28(9):1663-1666.
|
| 4. |
Ficat RP. Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment[J]. J Bone Jiont Surg Br, 1985, 76(1):3-9.
|
| 5. |
Arlet J, Mazieres B. Natural development of non-traumatic osteonecrosis of the hip[J]. Acta Orthop Belg, 1999, 65(Suppl 1):47-50.
|
| 6. |
Orban H, C?rstoiu C, Adam R. Total hip arthroplasty in secondary systemic lupus erythematosus femoral head avascular necrosis[J]. Rom J Intern Med, 2007, 45(1):123-129.
|
| 7. |
Abu-Shakra M, Urowitz MB, Gladman DD, et al. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death[J]. J Rheumatol, 1995, 22(7):1259-1264.
|
| 8. |
Ward MM, Pyun E, Studenski S. Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort[J]. Arthritis Rheum, 1995, 38(10):1492-1499.
|
| 9. |
Takahashi T, De-La-Garza L, Ponce-De-Leon S, et al. Risk factors for operative morbidity in patients with systemic lupus erythematosus:an analysis of 63 surgical procedures[J]. Am Surg, 1995, 61(3):260-264.
|
| 10. |
Ito H, Matsuno T, Hirayama T, et al. Health-related quality of life in patients with systemic lupus erythematosus after medium to long-term follow-up of hip arthroplasty[J]. Lupus, 2007, 16(5):318-323.
|
| 11. |
Zangger P, Gladman DD, Urowitz MB, et al. Outcome of total hip replacement for avascular necrosis in systemic lupus erythematosus[J]. J Rheumatol, 2000, 27(4):919-923.
|
| 12. |
Henriques HF, Lebovic D. Defining and focusing perioperative steroid supplementation[J]. Am Surg, 1995, 61(9):809-813.
|
| 13. |
袁燕林, 呂厚山, 林劍浩, 等. 服用激素的類風濕關節炎患者人工全膝關節置換術[J]. 中華骨科雜志, 2003, 23(10):619-621.
|
| 14. |
曾春, 宋炎成, 蔡道章, 等. 系統性紅斑狼瘡合并股骨頭壞死行全髖關節置換術的特點及其并發癥的防治[J/CD]. 中華關節外科雜志:電子版, 2009, 3(4):454-458.
|
| 15. |
董健文, 黃冬梅, 戎利民, 等. Ⅰ期雙側全髖關節置換治療系統性紅斑狼瘡合并股骨頭壞死的早中期療效[J]. 中華損傷與修復雜志:電子版, 2008, 3(6):705-711.
|
| 16. |
黃立羨, 練克儉, 郭林新, 等. 系統性紅斑狼瘡激素治療后股骨頭壞死行人工全髖關節置換術圍手術期處理[J]. 臨床骨科雜志, 2012, 15(6):607-609.
|
| 17. |
郭予立, 胡奕山, 林本丹. 合并系統性紅斑狼瘡的股骨頭壞死患者行全髖關節置換術的療效評估[J]. 廣東醫學, 2013, 34(19):2984-2986.
|
| 18. |
Arabmotlagh M, Rittmeister M, Hennigs T. Alendronate prevents femoral periprosthetic bone loss following tota1 hip arthroplasty:prospective randomized double-blind study[J]. J Orthop Res, 2006, 24(7):1336-l341.
|